SCHEMBL14366019

SCHEMBL14366019

CNC(=O)N[C@@H]1CCCC[C@H]1C(=O)N(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
EPHX1 P07099 6/20 0.38
PSEN1 P49768 3/20 0.35
PSEN2 P49810 3/20 0.35
APH1B Q8WW43 3/20 0.35
NCSTN Q92542 3/20 0.35
APH1A Q96BI3 3/20 0.35
PSENEN Q9NZ42 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
GLI1 P08151 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
EPHX2 P34913 1/20 0.31
MMP2 P08253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24359208 0.82 CTSB (0.47) CTSBCTSSCTSKEPHX1PSEN1
SCHEMBL24358985 0.82 CTSB (0.47) CTSBCTSSCTSKEPHX1PSEN1
SCHEMBL14366020 0.80 PSEN1 (0.45) EPHX1PSEN1PSEN2APH1BNCSTN
SCHEMBL12522714 0.79 EPHX1 (0.48) EPHX1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL13888656 0.79 EPHX1 (0.48) EPHX1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL12588569 0.79 EPHX1 (0.48) EPHX1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL12522719 0.79 EPHX1 (0.48) EPHX1SMN1; SMN2LMNANPC1RAB9A
SCHEMBL13902258 0.77 PSEN1 (0.45) EPHX1PSEN1PSEN2APH1BNCSTN
SCHEMBL9005013 0.74 CTSB (0.58) CTSBCTSSCTSKEPHX1GLI1
SCHEMBL9005010 0.74 CTSB (0.58) CTSBCTSSCTSKEPHX1GLI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259855-A1 THIAZOLYL-DIHYDRO-INDAZOLE ROR1, RORB, RORA CTSB 4532/4885CTSS 4320/4885CTSK 3458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.